Facebook
Twitter
Telegram
Report an ErrorVBI Vaccines Financial Statements 2011-2024 | VBIV
Annual Financial Statements VBI Vaccines
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
9.65 M | 3.1 M | 597 M | 765 M | 166 M | 108 M | 176 M | 114 M | 68.3 M | 42.8 M | 60.4 M | 27 M | 160 M |
Shares |
15.6 M | 8.61 M | 255 M | 235 M | 119 M | 65.6 M | 44.2 M | 30 M | 5.35 M | 5 M | 5 M | 4.86 M | 1.97 M |
Historical Prices |
0.62 | 0.36 | 2.34 | 2.75 | 1.38 | 1.6 | 4.27 | 3.1 | 5.2 | 8.8 | 9.2 | 16.8 | 42.8 |
Net Income |
-92.8 M | -113 M | -69.8 M | -46.2 M | -54.8 M | -63.6 M | -39 M | -23.2 M | -65.9 M | -4.59 M | -6.65 M | -13.2 M | -18.9 M |
Revenue |
8.68 M | 1.08 M | 631 K | 1.06 M | 2.22 M | 3.36 M | 865 K | 548 K | - | - | - | - | - |
Cost of Revenue |
- | - | - | 9.17 M | 7.9 M | 4.51 M | 5.19 M | 3.67 M | 3.75 M | - | - | - | - |
Gross Profit |
- | - | - | -8.11 M | -5.68 M | -1.15 M | -4.33 M | -3.12 M | - | - | -4.64 M | -10.8 M | - |
Operating Income |
-79.9 M | -81.8 M | -68 M | -43.6 M | -52.4 M | -60.4 M | -37.3 M | -24.8 M | -23.8 M | - | - | - | - |
Interest Expense |
6.4 M | 4.01 M | 4.73 M | 2.71 M | 2.2 M | 2.63 M | 2.88 M | 324 K | 1.1 M | - | - | - | - |
EBITDA |
-77.9 M | -79.8 M | -66.2 M | -42 M | -44.9 M | -59.9 M | -36.6 M | -24.2 M | -4.13 M | -5.27 M | -7.34 M | -13.6 M | -17.6 M |
Operating Expenses |
88.6 M | 82.9 M | 68.7 M | 35.5 M | 40.4 M | 59.3 M | 33 M | 21.7 M | 4.14 M | 5.29 M | 7.38 M | 2.79 M | 17.6 M |
General and Administrative Expenses |
42.1 M | 56.1 M | 38.3 M | 20.7 M | 14.1 M | 20.8 M | 12 M | 11.8 M | 2.65 M | 1.42 M | 2.41 M | 2.78 M | 17.4 M |
All numbers in USD currency
Quarterly Income Statement VBI Vaccines
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
24.6 M | 23.9 M | 21.2 M | 8.61 M | 8.61 M | 8.61 M | 8.61 M | 8.61 M | 8.61 M | 258 M | 256 M | 255 M | 251 M | 247 M | 235 M | 217 M | 178 M | 178 M | 106 B | 97.7 B | 97.5 M | 97.3 M | 64.4 M | 64.3 M | 64.2 M | 56.7 K | 40.2 M | 40.1 M | 40 M | 37.3 K | 36.2 K | 36.2 M | 27.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-17.9 M | - | -20.4 M | -44.6 M | -27.8 M | - | -25.2 M | -45.7 M | -21.3 M | - | -15.8 M | -17.5 M | -17.6 M | - | -13 M | -9.51 M | -8.36 M | - | -16.2 M | -13.2 M | -14.6 M | - | -15.4 M | -16.7 M | -12.3 M | -11.5 M | -9.8 M | -9.01 M | -8.64 M | -8.41 M | -7.3 M | -7.3 M | -6.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.21 M | - | 6.62 M | 720 K | 485 K | - | 317 K | 346 K | 126 K | - | 107 K | 142 K | 301 K | - | 298 K | 184 K | 415 K | - | 647 K | 640 K | 360 K | - | 259 K | 234 K | 178 K | 201 K | 193 K | 344 K | 127 K | 137 K | 281 K | 281 K | 82 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.11 M | 2.06 M | 2.58 M | - | 1.98 M | 2.35 M | 1.18 M | - | 801 K | 1.07 M | 1.41 M | - | 1.33 M | 1.36 M | 1.28 M | - | 1.5 M | 2.58 M | 1.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-11.8 M | - | -10.1 M | -37 M | -19.5 M | - | -21.6 M | -22.9 M | -15.9 M | - | -15 M | -16.4 M | -15.7 M | - | -11.9 M | -8.14 M | -9.41 M | - | -16.1 M | -12.3 M | -13.8 M | - | -14.5 M | -15.7 M | -11.6 M | - | -9.14 M | -8.31 M | -8.85 M | - | -7.74 M | -16.2 M | -8.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.82 M | - | 1.54 M | 1.71 M | 1.43 M | - | 958 K | 901 K | 940 K | - | 1.03 M | 845 K | 1.81 M | - | 742 K | 682 K | 582 K | - | 626 K | 566 K | 480 K | - | 716 K | 716 K | 539 K | - | 742 K | 743 K | 704 K | - | -62 K | -90 K | -28 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-11.3 M | - | - | - | -19 M | - | -20 M | -21.9 M | -15.4 M | - | -13.7 M | -15.5 M | -15.3 M | - | -10.6 M | -7.34 M | -9.01 M | - | -15.3 M | -11.9 M | -13.7 M | - | -14.1 M | -15.4 M | -11.5 M | - | -8.6 M | -7.96 M | -8.68 M | - | -7.72 M | -15.7 M | -8.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
13 M | - | 16.7 M | 37.7 M | 20 M | - | 21.9 M | 23.2 M | 16 M | - | 15.1 M | 16.6 M | 16 M | - | 12.2 M | 8.33 M | 9.83 M | - | 16.8 M | 12.9 M | 14.2 M | - | 14.8 M | 16 M | 11.8 M | - | 9.33 M | 8.66 M | 8.97 M | - | -8.02 M | -16.6 M | 8.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.67 M | - | 9.04 M | 10.9 M | 13.3 M | - | 14.2 M | 15.1 M | 10.9 M | - | 9.69 M | 9.37 M | 6.75 M | - | 5.56 M | 3.9 M | 4.06 M | - | 9.41 M | 3.19 M | 3.96 M | - | 3.49 M | 3.99 M | 3.42 M | - | 2.8 M | 2.77 M | 3.04 M | - | 3.15 M | 8.27 M | 5.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency